AjayMajorMDMBA(he/him)

PubMed

• Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.
  Hira Mian, Maya Abdallah, Othman Salim Akhtar, Ajay Major, Mazie Tsang, Pallawi Torka> ;Journal of Geriatric Oncology. 2024 Apr 11
• Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial.
  Davila, E., Bradeen, X., Abbott, D., Zain, J., Kamdar, M., Neuwelt, A., Jasem, J., Porcu, P., Major, A., Major, A., Haverkos, B., Major, A., Bair, S., Smith, C.> ;Blood Advances. 2024 Feb 13
• Mixed-Methods Study of End-of-Life Experiences of Patients With Hematologic Malignancies in Social Hospice Residential Home Care Settings.
  Weisse, C., Melekis, K., Cheng, A., Konda, A., Major, A.> ;JCO Oncology Practice. 2024 Feb 2
• 1 citations
  Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving v...
  Minhajuddin, M., Stevens, B., Bosma, G., Abbott, D., Miltgen, N., Yuan, J., Treece, A., Jordan, C., Winters, A., Major, A., Siegele, B., Ewalt, M., Gutman, J., Pollyea...> ;Haematologica. 2023 Dec 14
• 1 citations
  Selection of bispecific antibody therapies or CAR-T cell therapy in relapsed lymphomas.
  Major, A., Kamdar, M.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
• 2 citations
  Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma.
  Benjamin A Derman, Jeffrey Zonder, Donna Reece, Craig Cole, Jesus Berdeja, Andrew T Stefka, Ajay Major, Andrew Kin, Kent Griffith, Jagoda Jasielec, Andrzej J Jakubowiak> ;Blood Advances. 2023 Oct 10
• The Great Imitator: Aggressive Non-Hodgkin Lymphoma Presenting as a Cervical Mass.
  Adam Knox, Marita Meyer, Jennifer L Michener, Ajay Major> ;The American Journal of Medicine. 2024 Feb 1
• 5 citations
  Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
  Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali K Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J V...> ;Blood Advances. 2023 Aug 22
• 8 citations
  Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
  Major, A., Major, A., Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, ...> ;American Journal of Hematology. 2023 Jun 1
• 6 citations
  Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
  Hira Mian, Tanya M Wildes, Ravi Vij, Matthew J Pianko, Ajay Major, Mark A Fiala> ;Blood Cancer Journal. 2023 May 10
• 2 citations
  EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
  Agrawal, P., David, K., Chen, Z., Sundaram, S., Kim, S., Vaca, R., Lin, Y., Singer, S., Malecek, M., Carter, J., Zayac, A., Kim, M., Reddy, N., Ney, D., Habib, A., Str...> ;Leukemia & Lymphoma. 2023 May 1
• The Reply.
  Douglas M Ornoff, Andrew Berry, Ajay Major> ;The American Journal of Medicine. 2023 Mar 1
• 3 citations
  Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.
  Ajay Major, Pierluigi Porcu, Bradley M Haverkos> ;Cancers. 2023 Feb 21
• 4 citations
  A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
  Benjamin A Derman, Ajai Chari, Jeffrey Zonder, Ajay Major, Andrew T Stefka, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej Jakubowiak> ;European Journal of Haematology. 2023 May 1
• 14 citations
  Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma ...
  Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, Tadeusz Kubicki, Paweł Robak, Adam Walter-Croneck, Jarosław Czyż, Agata Tyczyńska, Agnieszka Druzd-Sitek, Krzyszto...> ;The Lancet. Oncology. 2023 Feb 1
• 2 citations
  Longitudinal assessment of quality of life in indolent non-Hodgkin lymphomas managed with active surveillance.
  Ajay Major, Rachel Wright, Fay J Hlubocky, Sonali M Smith, Micah T Prochaska> ;Leukemia & Lymphoma. 2022 Dec 1
• 1 citations
  Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.
  Ajay Major, Edward R Scheffer Cliff, Daniel A Ermann, Urshila Durani, David A Russler-Germain> ;Ejhaem. 2022 Aug 1
• 13 citations
  Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Re...
  Benjamin A Derman, Ankit Kansagra, Jeffrey Zonder, Andrew T Stefka, David L Grinblatt, Larry D Anderson Jr, Sandeep Gurbuxani, Sunil Narula, Shayan Rayani, Ajay Major,...> ;JAMA Oncology. 2022 Sep 1
• 1 citations
  Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma.
  Ajay Major, Andrzej Jakubowiak, Benjamin Derman> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Nov 1
• 19 citations
  Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
  Abou-Ismail, M., Adam J Kanack, Bandana Singh, Gemlyn George, Krishna Gundabolu, Scott A Koepsell, Mouhamed Yazan Abou-Ismail, Karen A Moser, Kristi J Smock, David Gre...> ;American Journal of Hematology. 2022 May 1
• 3 citations
  Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.
  Ajay Major, Monica Palese, Ebru Ermis, Anthony James, Milena Villarroel, Federico Antillon Klussmann, Laila Hessissen, Jennifer Geel, Muhammad Saghir Khan, Rashmi Dalv...> ;JCO Global Oncology. 2022 Feb 1
• 9 citations
  Applications of Artificial Intelligence in Pediatric Oncology: A Systematic Review.
  Siddhi Ramesh, Timothy Shen, Ajay Major, Samuel L Volchenboum, Anoop Mayampurath, Mark A Applebaum, Sukarn Chokkara> ;JCO Clinical Cancer Informatics. 2021 Dec 1
• 7 citations
  DA-R-EPOCH vs R-CHOP in DLBCL: How do we choose?
  Ajay Major, Sonali M. Smith> ;Clinical Advances in Hematology & Oncology. 2021 Nov 1
• 7 citations
  Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
  Andrea C Lo, Ajay Major, Leanne Super, Burton Appel, Ananth Shankar, Louis S Constine, Lianna J Marks, Kara M Kelly, Monika L Metzger, Ilia N Buhtoiarov, Christine Mau...> ;Leukemia & Lymphoma. 2022 Aug 1
• 2 citations
  The Missing Factor(s): Disseminated Amyloidosis Causing Coagulopathy Refractory to Plasma Transfusion.
  Douglas M Ornoff, Eric Balaban, Ajay Major, Andrew Berry, Eric Young> ;The American Journal of Medicine. 2022 Jun 1
• Join now to see all

Abstracts/Posters

• Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma
  Ajay Major, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019